1-10 of 590
Person: Matthew Gubin
Matthew Gubin, PhD is a Parker Bridge Scholar and Instructor in the Department of Pathology and Immunology and in the Bursky...
Post: Research initiative aims to better understand link between immunotherapy, type 1 diabetes
The Parker Institute for Cancer Immunotherapy, in collaboration with the Juvenile Diabetes Research Foundation and Helmsley Charitable Trust, have formed a...
Post: Where Cancer-killing T-cells Come From
New research published today in Nature Medicine by scientists from the Stanford University School of Medicine and the Parker Institute for...
Post: How Scientists Built a ‘Living Drug’ to Beat Cancer
Emily Whitehead would be the world’s first kid to try an experimental cancer therapy, called CAR-T. Researchers were offering to reprogram...
Post: The Parker Institute looks to grow, leveraging outside donors and equity stakes
LOS ANGELES — Internet billionaire Sean Parker has spent hundreds of millions of dollars of his fortune — and almost entirely...
Post: Billionaire Sean Parker is nerding out on cancer research. Science has never seen anyone quite like him
It’s been more than three years since the man who helped build Napster, Facebook, and the internet as we know it...
Partner: Friends of Cancer Research
Advance cell therapy development by optimizing regulatory processes
Partner: The Leona M. and Harry B. Helmsley Charitable Trust
Understand, predict and prevent insulin-dependent diabetes following checkpoint therapy